Work

Analysis of serum biomarkers and tumor genetic alterations from a phase II study of lenvatinib in patients with advanced BRAF wild-type melanoma.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.9058

Authors: Pallavi Sachdev, Omid Hamid, Kevin Kim, Axel Hauschild, Steven O'Day, Corina Andresen, Yasuhiro Funahashi, Tadashi Kadowaki, James P. O'Brien, Keith Flaherty

Institutions: Eisai (United States), Angeles Clinic and Research Institute, The University of Texas MD Anderson Cancer Center, University Hospital Schleswig-Holstein, Beverly Hills Cancer Center, Harvard University, Massachusetts General Hospital

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2596789009

Cites:

Cited by: 2

Related to: 10